Skip Ribbon Commands
Skip to main content
Menu

NCC Research Fund

Plans are underway for the NCC Research Fund to be subsumed under the umbrella of SingHealth Fund (SHF) as part of the NCCS Cancer Fund in the next few years. NCCS’ Community Cancer Fund was subsumed under SHF as the NCCS Cancer Fund earlier. The causes that the NCCS Cancer Fund supports remain unchanged from those as intended by NCCS for its charitable funds, namely cancer research, cancer patient support and cancer education. Donors who have been giving regularly to the NCC Research Fund will be notified in due course.


Established in 2005, the NCC Research Fund serves as the flagship fundraising and grant-making channel of our Centre by providing seeding and bridging funds for an array of translational and clinical research programmes.

The NCC Research Fund fulfils three objectives:

  • Seeding funds to help our scientists’ kick-start worthy and emerging research projects. By so doing, they build a track record and would be able to apply for sustainable competitive grants from government agencies.
  • Bridging funds between government grant cycles when the need arises, in order to enable our scientists to work with productive momentum.
  • Advancement funds to enhance research related infrastructural capabilities, hardware, tools and processes.


With cancer accounting for more than one in four deaths in Singapore, the Centre plays a pivotal role in the holistic care and multidisciplinary-based treatment of cancer patients. Innovative medicine requires quality research and clinical research is an arduous undertaking. Our doctor-scientists require ample philanthropic support and public understanding in order to usher medical breakthroughs for the benefit of the community.

We firmly believe that today’s research will pave the way for a cure for cancer tomorrow.

Through your support in cancer research, there is hope of overcoming the greatest threat to lives. More lives can be saved.

NCC Research Fund is registered under the Charities Act as an Institution of Public Character (IPC) with an independent Board of Trustees.

Today's Research. Tomorrow's Cure.


Financial Information

Please click here to view.


Non-financial Information

​   FY2017 in Review    ​FY2016 in Review ​FY2014-2015 Year in Review 

                                          
(As the PDF file size is 3MB, it may take a few minutes to load.)

Charity Status

  • Charity Registration No.: 01897 
  • Charity Registration Date: 19 August 2005
  • Gov. Instrument: Rules & Regulations
  • ROS Registration No.: Not Applicable
  • Date of Establishment: 6 May 2005


IPC Status

  • Effective Date: 19 August 2020 to 18 August 2023
  • Member of Central Fund: Health Endowment Fund


NCC Research Fund Board of Trustees

Chairperson


Madam Ho Geok Choo
CEO,
Human Capital (Singapore) Pte Ltd

Members


Mr George Thia Peng Heok
Independent Director,
Yoma Strategic Holdings Limited



Mr Kaka Singh
Chairman and Senior Partner,
RSM Chio Lim LLP





Mr Ng Boon Yew
Chairman and CEO,
Raffles Campus Pte Ltd


Prof Soo Khee Chee
Surgeon,
Soo Khee Chee Surgery


Prof Tan Ser Kiat
Emeritus Consultant,
Singapore General Hospital


Prof William Hwang 
Senior Advisor, SingHealth,  
Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS),
Senior Consultant, Department of Haematology, NCCS and SGH


Mr Harry Ng
Executive Director,
HLM (International) Corporate Services Pte. Ltd


Ms Bianca Cheo Hui Hsin
Executive Director & Chief Operating Officer,
Mewah International Inc.

 

Co-opted Members


Mr Vikna Rajah
Head Tax & Trust, Co-head Private Wealth,
Rajah & Tann Singapore LLP





Ms Lim Lei Theng

Partner
Allen & Gledhill LLP               

Finance Committee

Chairman


Mr Ng Boon Yew
Chairman and CEO,
Raffles Campus Pte Ltd
Members



Mr Seow Choong Huei
Founder,
8818 Enterprises Private Limited


Mr George Thia Peng Heok
Independent Director,
Yoma Strategic Holdings Limited


Audit Committee

Chairperson


Mr Harry Ng
Executive Director,
HLM (International) Corporate Services Pte. Ltd
Members


Mr Kaka Singh
Chairman and Senior Partner,
RSM Chio Lim LLP



Mr Khor Boon Hong
Partner, Baker Tilly TFW LLP

  

Development and Advocacy Panel

Chairperson


Ms Bianca Cheo Hui Hsin
Executive Director & Chief Operating Officer,
Mewah International Inc.
Members


Ms Sharon Au
Investment Director,
Jolt Capital



Ms He Jihong
CEO, 
International Business Huazhu Group



Ms Fiona Leung
Managing Partner,
Olive Vista Capital 


Dr Tay Miah Hiang
Senior Consultant 
Medical Oncologist
OncoCare Cancer Centre


Mr Cayden Chang 
Founder,
Value Investing Academy (VIA)

Nomination Committee

Chairperson


Prof William Hwang 
Senior Advisor, SingHealth,
Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS),
Senior Consultant, Department of Haematology, NCCS and SGH
​Members


Prof Tan Ser Kiat
Emeritus Consultant,
Singapore General Hospital



Ms Shoba Gunasekaran
District Manager,
H&R Block Limited (Australia)



Mr Perry Lim
Executive Director,
Royal Golden Eagle


Madam Ho Geok Choo
CEO,
Human Capital (Singapore) Pte Ltd


Auditor

Ernst & Young